A controlled trial of desipramine in 18 men with posttraumatic stress disorder
- PMID: 2648867
- DOI: 10.1176/ajp.146.4.513
A controlled trial of desipramine in 18 men with posttraumatic stress disorder
Abstract
Eighteen male U.S. veterans meeting DSM-III criteria for posttraumatic stress disorder (PTSD) completed a 4-week double-blind, crossover study comparing administration of 200 mg/day of desipramine with placebo. Response was measured by using the Beck Depression Inventory, the Hamilton Rating Scale for Depression, the Hamilton Rating Scale for Anxiety, and the Impact of Event Scale. Overall, the only apparent response to desipramine was in some symptoms of depression; there were no changes in anxiety and other PTSD symptoms.
Comment in
-
Antidepressants in the treatment of PTSD.Am J Psychiatry. 1990 Feb;147(2):260. doi: 10.1176/ajp.147.2.260a. Am J Psychiatry. 1990. PMID: 2301678 No abstract available.
-
Measuring results of treatment of PTSD.Am J Psychiatry. 1989 Dec;146(12):1645-6. doi: 10.1176/ajp.146.12.aj146121645. Am J Psychiatry. 1989. PMID: 2686479 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
